Syndax Pharmaceuticals Inc (SNDX) - News Archive

The dawn of a new era in oncology was signaled this week as Syndax Pharmaceuticals announced the FDA approval of its innovative treatment, Revuforj (revumenib). This groundbreaking drug has set a new precedent in the re...

Understanding Syndax Pharmaceuticals’ Inducement Grants and Their Implications for Share PerformanceSyndax Pharmaceuticals, a commercial-stage biopharmaceutical company focused on innovating cancer therapies, recently m...